Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 3

Relationship between intrarenal renin-angiotensin activity and re-hospitalization in patients with heart failure with reduced ejection fraction

Pages
205–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Demographically and biochemically, the remaining 63 patients were compared according tothe NYHA functional classes and re-hospitalization status.Results: When the groups were compared in terms of N-terminal pro–B-type natriuretic peptide (NT-proBNP), UAGT, and high-sensitivity Creactiveprotein (Hs-CRP), it was found that these parameters were significantly higher in patients who were hospitalized more than two timesin the previous year [p<0.001; p=0.007; p<0.001, respectively].

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Heart failure (HF) is a clinical syndrome resulting from structural or functional damages.
📊
Key Findings & Data:Although clinical trials have shown that theplasma renin–angiotensin system (RAS) activation decreases HF functional status and increases hospitalization for HF patients, the effect ofintrarenal RAS activity is still unknown.
💡
Conclusion & Impact:Demographically and biochemically, the remaining 63 patients were compared according tothe NYHA functional classes and re-hospitalization status.Results: When the groups were compared in terms of N-terminal pro–B-type natriuretic peptide (NT-proBNP), UAGT, and high-sensitivity Creactiveprotein (Hs-CRP), it was found that these parameters were significantly higher in patients who were hospitalized more than two timesin the previous year [p<0.001; p=0.007; p<0.001, respectively].
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Heart failure (HF) is a clinical syndrome resulting from structural or functional damages. Although clinical trials have shown that theplasma renin–angiotensin system (RAS) activation decreases HF functional status and increases hospitalization for HF patients, the effect ofintrarenal RAS activity is still unknown. In this study, we investigated the relationship between the New York Heart Association (NYHA) class,duration, and number of hospitalizations in the previous year and urinary angiotensinogen (UAGT) in patients with HF with reduced ejectionfraction (HFrEF).Methods: This study included 85 patients who had an ejection fraction of <40% and were receiving optimal medical treatment. Among these, 22were excluded from the study for various reasons. Demographically and biochemically, the remaining 63 patients were compared according tothe NYHA functional classes and re-hospitalization status.Results: When the groups were compared in terms of N-terminal pro–B-type natriuretic peptide (NT-proBNP), UAGT, and high-sensitivity Creactiveprotein (Hs-CRP), it was found that these parameters were significantly higher in patients who were hospitalized more than two timesin the previous year [p<0.001; p=0.007; p<0.001, respectively]. There was a significant correlation between number of hospitalizations and NTproBNP(r=0.507, p<0.001), Hs-CRP (r=0.511, p<0.001), hemoglobin (r=0.419, p=0.001), serum sodium (r=0.26, p=0.04), and systolic blood pressure(r=0.283, p=0.02). When the independence of multiple correlations was assessed using multiple linear regression analysis, NT-proBNP,Hs-CRP, and hemoglobin levels were independent predictors of re-hospitalization, but this was not the same for UAGT.Conclusion: Although UAGT levels are high in patients with poor NYHA functional class and repeated hospitalizations, this marker is not valuable for predicting repeated hospitalization in patients with HFrEF.

🔖

Cite This Article

ÖRSÇELİK, Ö., ÖZKAN, B., ARSLAN, A., ŞAHİN, E. E., SAKARYA, O., SÜRMELİ, O. A., FİDANCI, Ş. B., ÇELİK, A., ÇİMEN, M. B. Y., ÖZCAN, İ. T. (2018). Relationship between intrarenal renin-angiotensin activity and re-hospitalization in patients with heart failure with reduced ejection fraction. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 3, 205–212. https://ajindex.com/articles/366826

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Redondo-Bermejo B, Pascual-Figal DA, Hurtado-Martínez JA, Montserrat-Coll J, Peñafiel-Verdú P, Pastor-Pérez F, et al. Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure. Rev Esp Cardiol 2007; 60: 597- 606. [CrossRef] O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006; 113: 986-94.
  2. Lourenço P, Paulo Araújo J, Paulo C, Mascarenhas J, Friões F, Azevedo A, et al. Higher C-reactive protein predicts worse prognosis in acute heart failure only in noninfected patients. Clin Cardiol 2010; 33: 708-14. [CrossRef] Jug B, Salobir BG, Vene N, Sebestjen M, Sabovic M, Keber I. Interleukin-6 is a stronger prognostic predictor than high-sensitive Creactive protein in patients with chronic stable heart failure. Heart Vessels 2009; 24: 271-6. [CrossRef] O'Connor CM, Hasselblad V, Mehta RH, Tasissa G, Califf RM, Fiuzat M, et al. Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol 2010; 55: 872-8. [CrossRef] Omar HR, Guglin M. Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes. Int J Cardiol 2016; 218: 120-5.
  3. Caldeira D, David C, Sampaio C. Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis. Am J Cardiovasc Drugs 2012; 12: 263-77. [CrossRef] Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, et al. Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial. PLoS One 2016; 11: e0164936. [CrossRef] Komine N, Khang S, Wead LM, Blantz RC, Gabbai FB. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Am J Kidney Dis 2002; 39: 159-64. [CrossRef] Schunkert H, Tang SS, Litwin SE, Diamant D, Riegger G, Dzau VJ, et al. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res 1993; 27: 731- 5. [CrossRef] Kutlugün AA, Altun B, Akt